There is currently an imbalance between the supply and demand of functional red 37 blood cells (RBCs) in clinical applications, and this imbalance can be addressed by 38
Introduction this differentiation represents the second wave of hematopoiesis in the yolk sac [21] . 87
HSCs can also be directly produced through endothelial-hematopoietic transition 88 (EHT) induced by GATA2 and RUNX1 [22] [23] [24] . This occurs in the 89 aorta-gonad-mesonephros (AGM) region that maintains lifelong hematopoietic 90 differentiation and the hematopoietic cycle [25] , and these cells can differentiate into 91 definitive RBCs that express only adult globin and are regulated by signaling pathways 92 such as VEGF and HIF [26, 27] . Hematopoietic differentiation is the differentiation 93 process of HSCs to form various types of blood cells [28] . After differentiation and 94 activation of HSCs, it is necessary to go through the cell fate determination program 95 regulated by GATA1, KLF1 and other TFs to enter the erythroid differentiation 96 process [29] . The generation of RBCs is a complex multistep process involving the 97 differentiation of early erythroid progenitor cells into definitive RBCs, which require 98 spatiotemporal specific completion of globin synthesis and assembly [30, 31] , iron 99 metabolism [32, 33] , heme synthesis [34] , cell denucleation and other processes, 100 eventually forming intact functional RBCs [35] . However, the molecular and cellular 101 mechanisms involved in these processes are still poorly understood. 102
Based on the existing molecular mechanisms of hematopoietic development and 103 erythroid differentiation, scientists simulate embryonic hematopoiesis [36] used the 104 spin EB method to regenerate HSPCs in vitro, and then induced the differentiation of 105 RBCs from iPSCs. However, the differentiation efficiency and denucleation rate of the 106 existing system is low, and the expression of adult globin is limited; these drawbacks 107 limit the clinical availability [37] . At the same time, iPSC differentiation is a complex 108 process, and flow cytometry and immunostaining have been used to determine the cell 109 types during iPSC differentiation culture. However, these methods are limited by the 110 number of fluorescent probes used, and it is not possible to solve important problems, 111 such as the cell composition and differentiation path of the iPSC differentiation system, 112 under high-resolution conditions. Recently, single-cell transcriptome technology has 113 been able to efficiently capture and identify rare and transient cell types, determine the 114 spatial or temporal localization of cells, and reconstitute gene regulatory networks, 115 helping scientists understand the mechanisms by which development and cell fate are determined [38] . In recent years, there have been many single-cell hematopoiesis 117 studies in vitro. By single-cell sequencing of embryoid bodies, researchers found that 118 naïve H9 ESCs have a stronger hematopoietic capacity than primer H9 ESCs [39] and 119 illuminated the heterogeneity of pluripotent stem cell-derived endothelial cell 120 differentiation [40] . Single-cell sequencing of D29 erythrocytes belonging to the 121 iPSC-derived erythroid differentiation system revealed that cells expressing β -globin 122 showed reduced transcripts encoding ribosomal proteins and increased expression of 123 ubiquitin-proteasome system members [41] . The lack of a complete single-cell 124 transcriptome map as iPSCs differentiate into RBCs does not allow scientists to 125
Results

iPSC cell line-derived HSPC production and erythropoiesis 144
Depending on the spin EB culture method, we used the iPSC cell line BC1 to collect 145 the suspension cells (SCs) through the cell strainer in the system after 14 days of culture 146 [42, 43] (Figure 1A) . The established culture system can effectively produce SCs. The 147 cell count analysis showed that the number of SCs on day 14 (D14) was approximately 148 10-fold higher than the number of iPSCs on D0 ( Figure 1B ). Flow cytometry analysis 149
showed that approximately 25.9±3.05% of the SCs expressed CD34, and 150 approximately 27.08±1.63% of the SCs expressed CD45, indicating that we collected a 151 certain percentage of HSPCs from the SCs ( Figure 1C ). We performed colony-forming 152 unit (CFU) assays on the collected SCs on D14. After 14 days of culture, blood lineage 153 colonies were observed under the microscope, indicating that the SCs have the potential 154 to differentiate into various blood lineage cells; and the CFU-GEMM colony showed a 155 slight rust red color, indicating that the erythroid cell colonies begin to express 156 hemoglobin ( Figure 1D ). Subsequently, we attempted to induce HSPCs in SCs for 157 erythroid differentiation. By assessing the changes in the expression of the cell surface 158 markers CD71 and CD235a at different time points ( Figure 1E ), we found that on D14 159 of the EB stage, the proportion of CD71 and CD235a double-positive cells in SCs 160 exceeded 30%, indicating that some cells in the system entered the erythroid 161 differentiation stage. On D28, more than 95% of cells expressed both CD71 and 162 CD235a ( Figure 1E ). Through Wright-Giemsa staining analysis, we observed that most 163 of the cells were at the end of erythroid differentiation, and some cells were denucleated 164 RBCs. In summary, we successfully obtained HSPCs by spin EB technology used the 165 iPSC cell line BC1 and induced HSPCs to enter the erythroid differentiation process, 166 eventually producing denucleated RBCs. 167 both EBs and SCs, and the SCs contain a certain proportion of CD34+, CD45+ and 170 CD71+ CD235a+ cells, including various cell types; in addition, the cell number is l arge and the differentiation system is stable. Therefore, to establish the cell lineage 172 and developmental trajectory of the iPSC-derived RBC differentiation system, we 173 selected EB cells (EBCs) and SCs on D14 of culture and sequenced them using a 10× 174 Genomics platform. After sequencing and data processing, we detected 470,711,092 175 reads and 4,441 cells, with an average of 105,992 reads per cell; these reads 176 corresponded to 5,888 unique molecular identifier (UMI) counts and 1,644 genes. 177
Analysis of the cell composition of the iPSC-derived RBC differentiation system
After quality control analysis of the data by Seurat [44], we finally obtained 3,215 178 cells with high-quality transcripts, including 704 SCs and 2,511 EBCs ( Figure S1A ). 179
The t-SNE analysis at the sample level revealed that the cells were mainly divided 180 into upper and lower parts. EBCs were mainly distributed in the upper part, and the 181 corresponding highly expressed genes were mainly related to mesoderm 182 differentiation. SCs were mainly distributed in the lower part, and the corresponding 183 highly expressed genes mainly regulate hematopoietic differentiation and immune 184 function (Figure 2A , S1B and C). We also performed bulk RNA-seq on SCs cultured 185 at D14 and the iPSC line BC1. After comparing them with published HSPC 186 transcriptome data from human cord blood, we found that SCs are significantly 187 different from iPSCs, and the hematopoietic lineage-related gene expression patterns 188 of which are similar to HSPCs and exhibit HSPC-like characteristics ( Figure S1D and 189 E). Subsequently, the intersection of the top 2,000 genes in EBCs and SCs was 190 selected for further principal component analysis (PCA) and t-SNE analysis. The 191 results showed that the differentiation process of cells was not synchronized. Seurat 192 analysis divided our samples into ten clusters, including three progenitor cells clusters 193 (cluster 9 mainly include pluripotent stem cells and high gene expression of ZFP42; 194 cluster 1, 2 mainly include mesoderm cells and high gene expression of PDGFRA); 195 CD33 cells cluster (cluster 0, high gene expression of MNDA and S100A8); SCs were mainly distributed in blood cell clusters, such as clusters 0, 4, 7, and 8, and 207
EBCs were scattered and distributed in almost every cluster ( Figure S2B ); however, 208 the MEs cluster was almost entirely made of SCs, which may be because the RBCs 209 had low adhesion and were more easily released from the EBs (Figure 2A and B). 210
To further determine the function of the cell cluster, we performed functional 211 annotations based on the top 50 genes expressed in each cluster. Gene annotation 212 analysis revealed that progenitor cells-9 cluster genes were particularly involved in 213 the function of embryonic morphogenesis (P = 1.7E-05), and the results also indicated 214 that the progenitor cells-9 cluster had the differentiation potential to form each germ 215 layer cell, such as kidney, podosoma, epithelial cells and sensorium. The progenitor 216 cells-1 cluster was characterized by gastrula cells, and highly expressed genes were 217 enriched in gastrulation (P = 6.01E-03). Gene annotation analysis results of the 218 progenitor cells-1 cluster showed that these cells respond to growth factor stimulation 219 and highly expressed the genes related to organ growth and tissue morphogenesis. 220
Genes that were highly expressed in the progenitor cells-2 cluster were enriched in 221 mesoderm formation (P = 1.55E-05), which was related to cardiac development and 222 muscle formation, indicating that the progenitor cell-2 cluster was lateral 223 mesoderm-like mesoderm. Genes that were highly expressed in the mesenchymal 224 cells cluster were enriched in the connective tissue development pathway (P = 225 1.40E-06). Hemangioblasts cluster had the characteristics of hematopoietic 226 endothelium (HE), and highly expressed genes were enriched in the pathways of 227 endothelial development (P = 1.02E-08) and endothelial cell migration (P = 228 2.04E-04), suggesting that the hemangioblasts cluster simultaneously undergoes EHT 229 and highly expresses cell adhesion-related genes. Hemangioblasts further differentiated into VECs and HSPCs. Genes that were highly expressed in VECs were 231 mainly enriched in the function of blood vessel development (P = 3.94E-03). Genes 232 that were highly expressed in HSPCs were enriched in the pathways of lymphocyte 233 differentiation (P = 3.94E-03), erythrocyte differentiation (P =9.58E-03), and myeloid 234 cell differentiation (P = 1.49E-03), suggesting that HSPCs have the potential to 235 differentiate into myeloid, lymphoid and erythroid cells. Genes that were highly 236 expressed in the CD33 cells, MEs and CD14 cells clusters were obviously enriched in 237 the pathways of granulocyte activation (P = 5.32E-35), oxygen transport (P = 238 2.18E-08), and phagocytosis (P = 9.33E-05), respectively, and these clusters all 239 differentiated from HSPCs ( Figure S3 ). 240
A higher resolution clustering of the scRNA-seq data 241
To further determine the process of cell differentiation, we performed a higher 242 resolution clustering of the scRNA-seq data, and the results showed that clusters 0, 1, 243 4, and 8 had subclusters. Among them, the CD33 cells cluster had three subclusters, 244 which were recorded as 0a, 0b, and 0c. Compared with clusters 0b and 0c, cluster 0a 245 had increased CD14 and CTSS gene expression, indicating that cluster 0a was a 246 monocyte-like cells cluster [47] . Compared with clusters 0a and 0c, cluster 0b had 247 increased ELANE and MPO gene expression, suggesting that cluster 0b was a 248 granulocyte-macrophage progenitor (GMP)-like cells cluster. Compared with clusters 249 0a and 0b, cluster 0c had increased NFC1 and DEFA3 gene expression and was a 250 granulocyte-like cells cluster (Figure 3A and B). Cluster 1 had two subclusters that 251 were marked as clusters 1a and 1b. Cluster 1a had high expression levels of the PITX2 252 and PRRX1 genes, indicating that this cluster contained mesodermal cells; compared 253 with cluster 1a, cluster 1b showed more stem cell characteristics with high expression 254 of the PDGFRB and ID3 genes [48, 49] ( Figure 3A and C). The HSPCs cluster was 255 divided into 2 subclusters that were marked as clusters 4a and 4b. Cluster 4a was 256 characterized as a common myeloid progenitor (CMP)-like cluster and had the 257 potential for myeloid cell differentiation and had high PRG3 and PRG2 gene 258 expression; cluster 4b was characterized as a myeloid-lymphoid progenitor 259 (MLP)-like cluster with high EGR1 and TRDC gene expression [50]￼and was enriched in the pathways related to lymphocyte differentiation [50] . In addition, the 261 CD14 cells cluster was also divided into two clusters, namely, the macrophages 262 cluster (cluster 8a, high gene expression of CD36 and CD163) and the dendritic cells 263 cluster (cluster 8b, high gene expression of S100A8) [51] ( Figure S4 ). These results 264 indicated that the cells in our system originated from cluster 9, differentiated into the 265 
Dynamic regulation of cell adhesion molecules in hematopoietic development 271
To explain how endothelial characteristics lost during the formation of HSPCs, we 272 performed differentially expressed gene (DEG) analysis between HSPCs and 273 hemangioblasts and found that with the formation of HSPCs, the expression levels of 274 TFs, such as GATA2 and TAL1, were significantly increased, and the expression 275 levels of endothelial characteristic genes, such as TIE1 and KDR, were significantly 276 decreased ( Figure 3D ). Then, 466 genes that were significantly higher in HSPCs than 277 in hemangioblasts were intersected with the 1,639 human TFs retrieved from the TF 278 database [54], and 24 TFs were obtained. An interactive network analysis of these 24 279
TFs revealed that 4 of them were involved in erythroid differentiation, 4 TFs were 280 involved in lymphoid differentiation, 8 TFs were involved in myeloid differentiation, 281 and the others were potentially involved in hematopoietic differentiation ( Figure 3E ). 282 At the same time, compared with HSPCs, the functional annotations of the top 50 283 genes that were highly expressed in hemangioblasts showed significant enrichment in 284 hematopoietic differentiation pathways, such as the myeloid and lymphoid 285 differentiation pathways. The top 50 highly expressed genes in the hemangioblasts 286 were significantly enriched in the pathways of endothelial development and 287 PI3K-AKT signaling, and a number of genes were also found to be enriched in 288 pathways associated with cell adhesion; these genes were most highly expressed in 289 hemangioblasts ( Figure 3F and S5C). Making use of these genes for interaction network analysis, the inner circle on the interaction network map showed genes 291 enriched in the pathway, and the outer circle was genes that interacted with the inner 292 circle genes. We can see that the outer circle genes were characteristic of HE genes, 293 such as KDR, NOTCH4, and ERG, indicating that the outer circle genes were 294 necessary for the formation of hemangioblasts but were significantly lost during 295 hematopoietic differentiation [55, 56] . In addition, we found from the bulk RNA-seq 296 data that relative to iPSCs, SCs also downregulated the expression of cell 297 adhesion-related genes ( Figure S5E ), which may be the direct cause of SCs separation 298 from EBs. 299
Cell differentiation trajectory of the iPSC-derived RBC differentiation system 300
To further explain the differentiation trajectory of cells and the key factors affecting 301 cell differentiation, we performed a pseudotime analysis of scRNA-seq data using R 302 package Monocle [57] . The results also suggested that cell differentiation originated 303 from the progenitor cell clusters from hemangioblasts then experienced the first 304 bifurcation hemangioblasts. At the first bifurcation, cells differentiated into VECs and 305
HSPCs; then, at the second bifurcation, HSPCs differentiated into lymphoid cells 306 (Lyms) (small part cells) and CMPs (most part cells), and at the third bifurcation, 307
CMPs differentiated into MEs and granulocytes and monocytes (GMs) (Figure 4A  308 and B). Pseudotime heatmap analysis with 743 genes showed that all cells were 309 divided into three clusters, marked as early mesoderm cells, EPCs, and blood cells. 310
We compared the genes corresponding to the three clusters with the human TF 311 database. The TBX2 and PITX1 genes corresponding to the early mesodermal cells 312 cluster were involved in the differentiation of mesoderm, which guides mesodermal 313 organ formation and somite formation ( Figure 4C and D). The ETV2 and ERG genes 314 corresponding to the EPCs cluster could guide the cells to enter the hematopoietic 315 lineage, and the cluster also significantly expressed endothelial characteristic genes, 316 such as TIE1 and KDR ( Figure 4C genes showed that in the process of erythroid differentiation, the expression levels of 401 CD34 and TIE1 (endothelial marker genes) were downregulated and decreased 402 rapidly during the differentiation process. GATA1 was closely related to the early 403 differentiation of erythroid cells and was rapidly upregulated during the 404 differentiation process but was rapidly downregulated at the end of differentiation; 405 consistent with previous studies, TAL1 and GATA1 also showed similar trends [62] . 406 KLF1 and ALAS2 were also key factors during erythroid differentiation, and the 407 expression level gradually increased with the differentiation process; HBA1 and HBB 408 encoded adult-type globin, HBA1 was highly expressed throughout the erythroid 409 differentiation process, and the expression levels of both HBA1 and HBB gradually increased. FTH1 and FTL encoded ferritin, which were highly expressed throughout 411 the differentiation process and were gradually upregulated throughout the erythroid 412 differentiation process, which may be related to the synthesis of heme ( Figure 6C ). 413 Functional annotation results revelated that genes corresponding to MEPs were 414 enriched for the functions of embryonic hemopoiesis (P = 2.95E-05) and response to 415 estradiol (P = 7.72E-04). Functional annotation results of genes corresponding to Erys 416 showed significant enrichment in oxygen transport (P = 5.84E-13), erythrocyte 417 differentiation (P = 1.73E-07) and other RBC characteristic pathways. The target gene 418 of estradiol is highly expressed at the beginning of the erythroid differentiation 419 process, and then the expression level is reduced. The results indicate that estradiol 420 may promote the proliferation of erythroid progenitor cells with erythroid 421 differentiation but simultaneously inhibits erythroid differentiation ( Figure 6E ). The 422 interaction network analysis of the corresponding genes in the O 2 /CO 2 exchange in 423 erythrocytes, heme metabolic process and iron ion homeostasis pathways showed that 424 ALAS2, the hub gene in the interaction network, played a key role in the process of 425 erythroid differentiation and maturation [63] ( Figure 6F ). In addition, we mapped the 426 TFs of these 200 genes and the genes enriched in the pathways involved in erythroid 427 differentiation ( Figure S7B and C) . In addition, the β -chain globin expression profile 428 and the qPCR results corresponding to the erythroid cells in the data showed that the 429 erythroid cells produced by our iPSC system are mainly derived from yolk sac 430 hematopoiesis, and interestingly, during the hemangioblast formation period of D4 431 EBs [64], RBCs expressed HBG, which indicates that RBC production occurs before 432
HSPCs are formed during embryo culture ( Figure S7D ). 433
Our results showed that iPSCs entered erythroid differentiation, undergo two 434 transformations, exit pluripotency, and high expression of ETV2 and KDR under 435 BMP4 and VEGF stimulation to induce cells to differentiate into hemangioblasts; this 436 process is accompanied by cell adhesion activation [45, 55] . In addition, HSPCs enter 437 the erythroid differentiation process accompanied by the loss of cell adhesion and the 438 fluctuation of estradiol target genes expression. During this process, the HSPCs would 439 be induced by IKZF1 to undergo lymphoid differentiation, and induced by SPI1 to undergo myeloid differentiation; subsequently CMPs would be induced by MAFB to 441 enter granulocyte-mononuclear differentiation, and induced by GATA1 to enter 442 megakaryocyte-erythroid differentiation; lastly, MEPs would be induced by KLF1 to 443 enter erythroid differentiation ( Figure 6G) . We confirmed the expression trend of cell 444 adhesion-related genes (KDR, FN1, CD34, CDH5, CD99 and ESAM) in EB and SC 445 differentiation (Figure S7E , left) and estradiol target genes (ALAS2, GATA1 and 446 KLF1) in erythroid differentiation (Figure S7E By studying the differentiation trajectory of the iPSC-derived RBC differentiation 480 system, we found that the iPSCs differentiated enter hematopoietic lineage under the 481 driving force of ETV2 and underwent three bifurcations, then enter erythroid 482 differentiation process. During the process of the bifurcation of hematopoiesis and 483 angioblasts, the cells enter the hematopoietic lineage driven by TFs, such as GATA2 484 and RUNX1; in the process of bifurcation of the myeloid and lymphoid lines, the cells 485 enter the myeloid lineage driven by TF SPI1; and during the process the bifurcation of 486 the GMPs and MEPs, the cells enter the megakaryocyte-erythroid lineage driven by 487 GATA1, and then erythrocytes are formed under the driving force of KLF1. These 488 series of fate-determining TFs can effectivly guide the regulation of iPSC-derived 489 RBC differentiation process and provide estimable advice for cell regeneration in 490 other blood lineages. In addition, pseudotime clustering analysis also suggested that 491 the pluripotent stem cells to erythroid cell production underwent two major 492 transformations, including ETV2-directed withdrawal of iPSC pluripotency into the 493 hematopoietic lineage, followed by GATA1-directed HSPC erythroid differentiation. 494
We noted that cell adhesion molecules are actively expressed during the 495 transformation one process but are downregulated during transformation two, possibly 496 related to cell adhesion for the formation of the gastrula [55] . We found that during 497 iPSC-derived erythroid differentiation, estradiol promoted the proliferation of erythroid progenitor cells and inhibited erythroid differentiation. We were advised 499 that we could add a cell adhesion activator to stimulate the production of 500 hemangioblasts during the first four days of culturing EBs and then could add 501 estradiol to the medium 6 days before inducing SC differentiation to increase the 502 efficiency of RBC regeneration. In addition, a number of TFs that play a key role in 503 the differentiation and maturation of RBCs, such as NEF2 and MAX, have also been 504 discovered. This information provides a powerful theoretical guide for optimizing our 505 iPSC-derived RBC regeneration system. With the continuous development of 506 single-cell technology, we will be able to excavate more potential mechanisms 507 regulating RBC development and maturation and will be able to achieve the 508 development and differentiation of RBCs in our system, thereby obtaining more 509 mature regenerated functional RBCs in vitro for use in clinical applications. 510 511 Materials and methods 512 iPSC and EB culture and erythropoiesis 513 iPSCs, which the original source was Linzhao Cheng's lab, were cultured in 514 vitronectin (Life Technologies)-coated culture dishes with Essential 8 medium 515 (Gibco). When the cells reached 70% to 80% confluence (usually around 3~4 days), 516 they were digested to suspension cells using 0.5 mM EDTA (Invitrogen) and passaged 517 according to a ratio of 1 to 4. 518 EB culture was performed during D0 to D11 as previously described [68] . From 519 D11 to D14 of EB culture, TPO was replaced by 3 U/ml erythropoietin (EPO) 520 (PeproTech). On D14, SCs were collected by a 70 μ m cell strainer. Subsequently, the 521 SC solution was centrifuged at 300 g for 5 minutes to remove the supernatant, and 522 serum-free medium (SFM) containing 50 μ g/ml stem cell factor (SCF) (PeproTech), 523 100 μ g/ml IL-3 (PeproTech), 2 U/ml EPO and 1% penicillin/streptomycin (P/S) (Life 524 Technologies) was used to resuspend the SC precipitates. The cell concentration was 525 adjusted to 5 x 10 5 /ml and cultured in a 6-well plate at a total volume of 2 ml per well. 526
All cells were cultured for 6 days at 37 °C under 5% CO 2 , and the medium was 527 changed every three days. On D20, the medium was replaced with SFM containing 2 528 U/ml EPO and 1% P/S, and the cell concentration was adjusted appropriately. The 529 number of cells in each well did not exceed 2 x 10 6 , and the total volume of the 530 medium per well was 2 ml. The cells were cultured at 37 °C under 5% CO 2, and the 531 medium was changed every three days. 532
Colony formation unit assay 533
Incubation of D14 SCs used MethoCult™ H4434 Classic Methylcellulose Medium 534 for Human Cells (StemCell). Each well of a 12-well plate contained 8,000-10,000 535 cells and 0.6 ml of medium. Other operations were performed as described in the 536 instructions. Cells were incubated for 12-14 days, and the clones were observed under 537 the microscope. 538
Flow cytometry analysis 539
First, ~1 × 10 5 cells were collected from the culture, centrifuged at 300 g for 5 540 minutes to remove the medium, and washed twice with 2 ml 1 Wright-Giemsa staining 553 ~1 × 10 5 cells were taken, and the medium was removed by centrifugation at 300 g for 554 5 minutes; the cells were resuspended in 20 μ l of DPBS buffer. The cells were placed 555 onto one of two clean slides, and the other slide was used to push the slide at a 30 to 556 45-degree angle to spread the cells evenly. The pushed film was placed in a 37 °C 557 incubator for 1 to 3 hours. Then, 200 μ L of Wright-Giemsa staining A solution 558 (BASO, BA-4017) was placed onto the cell-containing slide, the slide was placed at 559 room temperature for 1 minute and was immediately covered with 400 μ L of B 560 solution. After the slide was incubated at room temperature for 8 minutes, the slides 561 were gently rinsed with fluid distilled water along the area around the slide without 562 cells. The slides were rinsed for an additional 1 minute until the water ran clear and 563 transparent. Then, the slides were placed at room temperature until dry, and a 564 microscope was used to observe and record cell morphology. 565
Total RNA extraction and qPCR 566
Total RNA was extracted from the iPSC line BC1, D4 EBs, D14 SCs, and D20 567 erythroid cells, and the total RNA was reverse transcribed into cDNA using the 568 PrimeScript RT Reagent Kit with gDNA Eraser (TaKaRa). The diluted cDNA was 569 used as a template for qPCR. The instrument used for qPCR was the Bio-Red CFX96 570
Real-Time PCR Detection System. All primers used in qPCR are listed in 571 Supplementary Table S7 . 572 scRNA-seq data analysis and bulk RNA-seq data analysis 573 D14 EBs were dissociated with Accutase solution (Sigma). Single-cell suspensions at 574 800 cells/µL were subjected to Chromium 10× Genomics library construction. Raw 575 gene expression matrices generated by CellRanger (version 2.0.0) were imported into 576 Seurat (version 2.4) [44] . After removing genes expressed in fewer than 5 cells, in 577 cells with more than 5% mitochondria reads or in cells with less than 200 unique 578 genes, two Seurat objects were integrated and clustered into 10 and 14 clusters based 579 on fifteen principal components with the resolution parameter set at 0.2 and 0.8. Each 580 cluster was identified according to the marker genes found by the Seurat 581 were shown, and genes were listed in Supplementary Table S4 . C. Heatmap shown 836 the DEG pattern of subclusters from progenitor cells-1 cluster. Top 50 DEGs of each 837 subcluster were shown, and genes were listed in Supplementary Table S4 . D. 838
Figure legends
Volcanic plot of DEGs from DEG analysis between HSPCs and hemangioblasts (P < 839 0.05, -1< Log2 FC <1). E. GO analysis of DEGs from DEG analysis between HSPCs 840 and hemangioblasts. Each functional term was shown in Supplementary Table S3 . Each functional term was shown in Supplementary Table S3 . 902 903 Table S6 . Figure 6B . Each functional 909 term was shown in Supplementary Table S6 . B, C. The network shown the TFs in 910 Figure 6B Table S1 Heatmap genes for Figure S1B and functional term for Figure S1C 915 916 Table S2 Heatmap genes for Figure 2C  917 918 Table S3 Functional terms for Figure S3 , 3F and S5E 919 920 Table S4 Genes used for heatmap of subclusters 0a, 0b, 0c, 1a, 1b, 4a, 4b, 8a and 8b 921 922 Table S5 Genes used for Figure 4C , 5A, 5C, 5F and 6B 923 924 Table S6 Functional terms for Figure 5A , 5C, 5F and 6B 925 926 Table S7 qPCR primer for globin, cell adhesion and estradiol related genes 927
Figure S6 Functional annotation analysis for the heatmap genes in Figures 4 and 904
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